These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23414143)

  • 61. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using
    Paul M; Kumar Panda M; Thatoi H
    J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular dynamics simulations reveal structural insights into inhibitor binding modes and mechanism of casein kinase II inhibitors.
    Ul-Haq Z; Ashraf S; Bkhaitan MM
    J Biomol Struct Dyn; 2019 Mar; 37(5):1120-1135. PubMed ID: 29527958
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
    He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y
    Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Atom-based 3D-QSAR, induced fit docking, and molecular dynamics simulations study of thieno[2,3-b]pyridines negative allosteric modulators of mGluR5.
    Vijaya Prabhu S; Singh SK
    J Recept Signal Transduct Res; 2018 Jun; 38(3):225-239. PubMed ID: 29806525
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors.
    Zhang G; Ren Y
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30423939
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    Liu J; Feng K; Ren Y
    J Biomol Struct Dyn; 2019 Sep; 37(14):3803-3821. PubMed ID: 30261821
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Integrated molecular docking, 3D QSAR and molecular dynamics simulation studies on indole derivatives for designing new Pim-1 inhibitors.
    Peddi SR; Peddi SR; Sivan S; Veerati R; Manga V
    J Recept Signal Transduct Res; 2020 Feb; 40(1):1-14. PubMed ID: 31931654
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II/IX by 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
    Wang Y; Guo H; Tang G; He Q; Zhang Y; Hu Y; Wang Y; Lin Z
    Comput Biol Chem; 2019 Jun; 80():234-243. PubMed ID: 31009872
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Novel Allosteric Mechanism of NF-κB Dimerization and DNA Binding Targeted by an Anti-Inflammatory Drug.
    Ashkenazi S; Plotnikov A; Bahat A; Ben-Zeev E; Warszawski S; Dikstein R
    Mol Cell Biol; 2016 Apr; 36(8):1237-47. PubMed ID: 26830231
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Integrated machine learning, molecular docking and 3D-QSAR based approach for identification of potential inhibitors of trypanosomal N-myristoyltransferase.
    Singh N; Shah P; Dwivedi H; Mishra S; Tripathi R; Sahasrabuddhe AA; Siddiqi MI
    Mol Biosyst; 2016 Nov; 12(12):3711-3723. PubMed ID: 27766319
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design, synthesis and biological evaluation of dihydrofurocoumarin derivatives as potent neuraminidase inhibitors.
    Zhong ZJ; Cheng LP; Pang W; Zheng XS; Fu SK
    Bioorg Med Chem Lett; 2021 Apr; 37():127839. PubMed ID: 33556571
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biological evaluation, chelation, and molecular modeling studies of novel metal-chelating inhibitors of NF-kappaB-DNA binding: structure activity relationships.
    Sharma RK; Chopra S; Sharma SD; Pande V; Ramos MJ; Meguro K; Inoue J; Otsuka M
    J Med Chem; 2006 Jun; 49(12):3595-601. PubMed ID: 16759101
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Improved 3D-QSAR prediction by multiple-conformational alignment: A case study on PTP1B inhibitors.
    Zhang X; Mao J; Li W; Koike K; Wang J
    Comput Biol Chem; 2019 Dec; 83():107134. PubMed ID: 31629257
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Exploring the inhibitory potential of bioactive compound from Luffa acutangula against NF-κB-A molecular docking and dynamics approach.
    Ramar V; Pappu S
    Comput Biol Chem; 2016 Jun; 62():29-35. PubMed ID: 27061144
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structural determinants of benzodiazepinedione/peptide-based p53-HDM2 inhibitors using 3D-QSAR, docking and molecular dynamics.
    Wang F; Li Y; Ma Z; Wang X; Wang Y
    J Mol Model; 2012 Jan; 18(1):295-306. PubMed ID: 21523548
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
    Buolamwini JK; Assefa H
    J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB.
    Choi M; Jo H; Park HJ; Sateesh Kumar A; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee K; Kwak JH; Lee H
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2545-9. PubMed ID: 25953156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.